Apretude (cabotegravir) is a long-acting injection used to lower the risk of getting an HIV infection in people at risk. It's an antiviral medication that's FDA approved for pre-exposure prophylaxis (PrEP), which means it helps prevent HIV before you're exposed to it. The injection is typically given every other month as a shot in the buttock muscle by a healthcare professional. The most common side effects are injection site reactions like pain, redness, and hardening of the skin.
Apretude (cabotegravir) is an integrase inhibitor. It works by blocking an enzyme (protein) called integrase that HIV uses to insert its genetic material into your cells. By stopping this step, the virus can't cause an infection in your body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
In studies, for cisgender men and transgender women, Apretude (cabotegravir) reduced the risk of getting HIV by 67% compared to taking a daily Truvada (emtricitabine/tenofovir) pill. And for cisgender women, Apretude (cabotegravir) lowered the risk by 88% compared to a daily Truvada (emtricitabine/tenofovir) pill.
Yes, women can take Apretude (cabotegravir) for HIV PrEP. It's FDA approved for use in people 12 years and older who weigh at least 77 lbs, including cisgender and transgender women.
Yes. Apretude (cabotegravir) should be kept in the refrigerator at your prescriber's office until it's ready for use. The medication should be brought to room temperature before the injection to help reduce pain during the shot.
Apretude (cabotegravir) can stay in your body for 12 months or longer after you stop taking it. But that doesn’t mean it will keep protecting you that whole time. After about 2 months, the amount of medication in your system gets too low to work well. To stay protected from HIV, you need to get this medication every 2 months.
It isn't known exactly how long it takes for Apretude (cabotegravir) to start working, and this can vary from person to person. Studies show that it takes about a week to reach protective levels in your body, but about 50% of people reach those levels just 1 day after the shot. Talk to your prescriber if you have questions about how soon this medication will start protecting you.
No, Apretude (cabotegravir) isn't a vaccine. It's an antiviral medication that prevents HIV infection in your body as long as there's enough of the medication in your blood.
Apretude (cabotegravir) is a prescription medication that must be given by a healthcare professional. Talk to your healthcare professional to see if Apretude (cabotegravir) is right for you based on your HIV risk and overall health. Once prescribed, it's usually injected by a healthcare professional in their office, but you might also be able to receive it at a public health clinic.
Protection from Apretude (cabotegravir) against HIV lasts for 2 months after you complete the starting doses. To stay protected, it's important to keep getting your injection on time every 2 months.
Apretude (cabotegravir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Apretude (cabotegravir) can help lower your risk of getting HIV, but it works best when used with other protection methods. This includes getting your injections on time and practicing safer sex, like using condoms and getting tested regularly for STIs.
Before starting Apretude (cabotegravir), your prescriber might ask you about any recent situations where you could have been exposed to HIV — like unprotected sex or a recent STI. You'll also need to take an HIV test before each injection. Let your prescriber know if you have symptoms of HIV, such as fever, feeling tired, muscle pain, and skin rash, either before or during treatment.
There’s a chance that HIV could become harder to treat if you get infected before, during, or shortly after stopping Apretude (cabotegravir). To help prevent this, your prescriber will test you for HIV before each injection to make sure you’re still HIV-negative. If you test positive, you’ll need to switch to full HIV treatment.
If you stop getting Apretude (cabotegravir) but are still at risk for HIV, your prescriber might recommend another type of PrEP. It's best to start the new medication within 2 months after your last injection.
Apretude (cabotegravir) can stay in your body for up to 12 months or longer after your last injection. That’s why it’s important to get your shots on time every 2 months. Missing doses can raise your risk of getting HIV and make the virus harder to treat if you do get infected.
Some people have had serious allergic reactions while taking cabotegravir, the active ingredient in Apretude (cabotegravir). In rare cases, these reactions have included serious skin problems like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). In studies, some people started with Vocabria (cabotegravir) tablets first to help spot early signs of a reaction before getting injections. Stop taking the medication right away and call your care team if you get a severe rash or a rash with other symptoms like fever, feeling very tired, muscle or joint pain, blisters, mouth sores, red or irritated eyes, facial swelling, or trouble breathing.
Liver problems have been reported in some people taking Apretude (cabotegravir), even in those without known liver issues. Your prescriber might check your liver with blood tests during treatment to watch for any signs of damage. Call your prescriber right away if you notice signs of liver problems like pain in the upper right side of your stomach, yellowing of your skin or eyes, dark urine, pale stools, nausea, vomiting, loss of appetite, or itching.
Mood changes, including depression and suicidal thoughts of behavior, have been reported in some people taking Apretude (cabotegravir). If you or someone close to you notices any changes in your mood, call your prescriber right away. They will help decide if it’s safe for you to keep taking Apretude (cabotegravir).
Apretude (cabotegravir) can interact with many other medications. These interactions can lead to side effects, making the medication not work as it should for preventing HIV. Before and while taking Apretude (cabotegravir), tell your prescriber about everything you take — prescription, over-the-counter products, and supplements — so they can help manage any possible interactions.
Apretude (cabotegravir) is approved for adults and teens ages 12 and older, weighing at least 35 kg (77 lbs).
The typical starting dose is one 600 mg injection into the buttock muscle once a month for 2 months. After that, the maintenance dose is one 600 mg injection once every 2 months.
*Note: You might need to take Vocabria (cabotegravir) tablets for about a month before receiving Apretude (cabotegravir) injections.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Apretude (cabotegravir) will not be safe for you to take.